Research ExplorerScientific StaffKatja Weisel Publications

Prof.Dr.med. ID: 6488383

Katja Weisel

graph of relations
Affiliations
101 - 150 out of 245Page size: 50
Sort by: Title

Publications

  1. Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR

    Avet-Loiseau, H., San-Miguel, J., Casneuf, T., Iida, S., Lonial, S., Usmani, S. Z., Spencer, A., Moreau, P., Plesner, T., Weisel, K., Ukropec, J., Chiu, C., Trivedi, S., Amin, H., Krevvata, M., Ramaswami, P., Qin, X., Qi, M., Sun, S., Qi, M., Kobos, R. & Bahlis, N. J., 01.04.2021, In: J CLIN ONCOL. 39, 10, p. 1139-1149 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  2. Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

    Dimopoulos, M. A., Leleu, X., Palumbo, A., Moreau, P., Delforge, M., Cavo, M., Ludwig, H., Morgan, G. J., Davies, F. E., Sonneveld, P., Schey, S. A., Zweegman, S., Hansson, M., Weisel, K., Mateos, M. V., Facon, T. & Miguel, J. F. S., 08.2014, In: LEUKEMIA. 28, 8, p. 1573-85 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  3. Extended in vitro expansion of adult, mobilized CD34+ cells without significant cell senescence using a stromal cell coculture system with single cytokine support

    Weisel, K. C., Moore, M. A. S., Kanz, L. & Möhle, R., 03.2009, In: STEM CELLS DEV. 18, 2, p. 229-34 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Extracorporeal light chain elimination: high cut-off (HCO) hemodialysis parallel to chemotherapy allows for a high proportion of renal recovery in multiple myeloma patients with dialysis-dependent acute kidney injury

    Heyne, N., Denecke, B., Guthoff, M., Oehrlein, K., Kanz, L., Häring, H-U. & Weisel, K. C., 05.2012, In: ANN HEMATOL. 91, 5, p. 729-735 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study

    Usmani, S. Z., Quach, H., Mateos, M-V., Landgren, O., Leleu, X., Siegel, D. S., Weisel, K. C., Shu, X., Li, C. & Dimopoulos, M. A., 25.07.2023, In: BLOOD ADV. 7, 14, p. 3739-3748 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

    Facon, T., Dimopoulos, M. A., Dispenzieri, A., Catalano, J. V., Belch, A., Cavo, M., Pinto, A., Weisel, K., Ludwig, H., Bahlis, N. J., Banos, A., Tiab, M., Delforge, M., Cavenagh, J. D., Geraldes, C., Lee, J-J., Chen, C., Oriol, A., De La Rubia, J., White, D., Binder, D., Lu, J., Anderson, K. C., Moreau, P., Attal, M., Perrot, A., Arnulf, B., Qiu, L., Roussel, M., Boyle, E., Manier, S., Mohty, M., Avet-Loiseau, H., Leleu, X., Ervin-Haynes, A., Chen, G., Houck, V., Benboubker, L. & Hulin, C., 18.01.2018, In: BLOOD. 131, 3, p. 301-310 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. First-in-Human Phase I Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma

    Vij, R., Nath, R., Afar, D. E. H., Mateos, M. V., Berdeja, J. G., Raab, M. S., Guenther, A., Martinez-Lopez, J., Jakubowiak, A. J., Leleu, X., Weisel, K., Wong, S., Gulbranson, S., Sheridan, J. P., Reddy, A., Paiva, B., Singhal, A., San-Miguel, J. F. & Moreau, P., 15.05.2020, In: CLIN CANCER RES. 26, 10, p. 2308-2317 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Follow-up of patients with refractory or relapsed multiple myeloma after allogeneic hematopoietic cell transplantation

    Schneidawind, C., Duerr-Stoerzer, S., Faul, C., Kanz, L., Weisel, K., Bethge, W. & Schneidawind, D., 07.2017, In: CLIN TRANSPLANT. 31, 7

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trial

    Schmitt, M., Hückelhoven, A. G., Hundemer, M., Schmitt, A., Lipp, S., Emde, M., Salwender, H., Hänel, M., Weisel, K., Bertsch, U., Dürig, J., Ho, A. D., Blau, I. W., Goldschmidt, H., Seckinger, A. & Hose, D., 17.10.2017, In: ONCOTARGET. 8, 49, p. 84847-84862 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparison

    Moreau, P., Hebraud, B., Facon, T., Leleu, X., Hulin, C., Hashim, M., Hu, Y., Caillot, D., Benboubker, L., Zweegman, S., Merz, M., Weisel, K., Salwender, H., Mai, E. K., Goldschmidt, H., Bertsch, U., Vanquickelberghe, V., Kampfenkel, T., Boer, C. D., Krotneva, S., Proskorovsky, I., He, J., Lam, A., Lee, C., Cote, S. & Sonneveld, P., 02.2021, In: IMMUNOTHERAPY-UK. 13, 2, p. 143-154 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Genetic and functional characterization of isolated stromal cell lines from the aorta-gonado-mesonephros region

    Weisel, K. C. & Moore, M. A. S., 06.2005, In: ANN NY ACAD SCI. 1044, p. 51-9 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  12. Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials

    Laane, E., Salek, S., Oliva, E. N., Bennink, C., Clavreul, S., Richardson, P. G., Scheid, C., Weisel, K., Ionova, T. & European Hematology Association Specialized Working Group on Quality of Life and Symptoms, 08.12.2023, In: CANCERS. 15, 24, 5764.

    Research output: SCORING: Contribution to journal › Guideline, recommendation, statement › Research › peer-review

  13. Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells

    Hambach, J., Fumey, W., Stähler, T., Gebhardt, A. J., Adam, G., Weisel, K., Koch-Nolte, F. & Bannas, P., 2022, In: FRONT IMMUNOL. 13, 838406.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma

    Song, K. W., Dimopoulos, M. A., Weisel, K. C., Moreau, P., Palumbo, A., Belch, A., Schey, S., Sonneveld, P., Sternas, L., Yu, X., Amatya, R., Monzini, M. S., Zaki, M., Jacques, C. & San Miguel, J., 02.2015, In: HAEMATOLOGICA. 100, 2, p. e63-7

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Health-related quality of life in the ENDEAVOR study: carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma

    Ludwig, H., Moreau, P., Dimopoulos, M. A., Mateos, M-V., Kaiser, M., Hajek, R., Feng, S., Cocks, K., Buchanan, J. & Weisel, K., 22.02.2019, In: BLOOD CANCER J. 9, 3, p. 23

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial

    Perrot, A., Facon, T., Plesner, T., Usmani, S. Z., Kumar, S., Bahlis, N. J., Hulin, C., Orlowski, R. Z., Nahi, H., Mollee, P., Ramasamy, K., Roussel, M., Jaccard, A., Delforge, M., Karlin, L., Arnulf, B., Chari, A., He, J., Ho, K. F., Van Rampelbergh, R., Uhlar, C. M., Wang, J., Kobos, R., Gries, K. S., Fastenau, J. & Weisel, K., 20.01.2021, In: J CLIN ONCOL. 39, 3, p. 227-237 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Health-related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial

    Hungria, V., Beksac, M., Weisel, K. C., Nooka, A. K., Masszi, T., Spicka, I., Munder, M., Mateos, M-V., Mark, T. M., Qi, M., Qin, X., Fastenau, J., Spencer, A., Sonneveld, P., Garvin, W., Renaud, T. & Gries, K. S., 05.2021, In: BRIT J HAEMATOL. 193, 3, p. 561-569 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Health-related quality of life of carfilzomib- and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma, based on German benefit assessment data

    Weisel, K., Ludwig, H., Rieth, A., Lebioda, A. & Goldschmidt, H., 01.2020, In: QUAL LIFE RES. 29, 1, p. 69-79 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Health-related quality of life outcomes from the CANDOR study in patients with relapsed or refractory multiple myeloma

    Siegel, D., Weisel, K., Zahlten-Kumeli, A., Medhekar, R., Ding, B. & Leleu, X., 12.2021, In: LEUKEMIA LYMPHOMA. 62, 12, p. 3002-3010 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma

    Weisel, K., Dimopoulos, M., Moreau, P., Yagci, M., Larocca, A., Kanate, A. S., Vural, F., Cascavilla, N., Basu, S., Johnson, P., Byeff, P., Hus, M., Rodríguez-Otero, P., Muelduer, E., Anttila, P., Hayden, P. J., Krauth, M-T., Lucio, P., Ben-Yehuda, D., Mendeleeva, L., Guo, S., Yu, X., Grote, L., Biyukov, T., Dhanasiri, S. & Richardson, P., 08.2020, In: LEUKEMIA LYMPHOMA. 61, 8, p. 1850-1859 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial

    Hutchison, C. A., Cockwell, P., Moroz, V., Bradwell, A. R., Fifer, L., Gillmore, J. D., Jesky, M. D., Storr, M., Wessels, J., Winearls, C. G., Weisel, K., Heyne, N. & Cook, M., 04.2019, In: LANCET HAEMATOL. 6, 4, p. e217-e228

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial

    Lonial, S., Popat, R., Hulin, C., Jagannath, S., Oriol, A., Richardson, P. G., Facon, T., Weisel, K., Larsen, J. T., Minnema, M. C., Abdallah, A-O., Badros, A. Z., Knop, S., Stadtmauer, E. A., Cheng, Y., Amatangelo, M., Chen, M., Nguyen, T. V., Amin, A., Peluso, T. & van de Donk, N. W. C. J., 11.2022, In: LANCET HAEMATOL. 9, 11, p. e822-e832

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

    Munshi, N. C., Anderson, L. D., Shah, N., Madduri, D., Berdeja, J., Lonial, S., Raje, N., Lin, Y., Siegel, D., Oriol, A., Moreau, P., Yakoub-Agha, I., Delforge, M., Cavo, M., Einsele, H., Goldschmidt, H., Weisel, K., Rambaldi, A., Reece, D., Petrocca, F., Massaro, M., Connarn, J. N., Kaiser, S., Patel, P., Huang, L., Campbell, T. B., Hege, K. & San-Miguel, J., 25.02.2021, In: NEW ENGL J MED. 384, 8, p. 705-716 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display

    Krohn, S., Boje, A. S., Gehlert, C. L., Lutz, S., Darzentas, N., Knecht, H., Herrmann, D., Brüggemann, M., Scheidig, A. J., Weisel, K., Gramatzki, M., Peipp, M. & Klausz, K., 2022, In: FRONT IMMUNOL. 13, 908093.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Imaging findings in relapsing multiple myeloma

    Sauter, A., Weisel, K. & Horger, M., 08.2010, In: BRIT J HAEMATOL. 150, 4, p. 388

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phase 2 ELOQUENT-3 Trial

    Weisel, K., Dimopoulos, M. A., San-Miguel, J., Paner, A., Engelhardt, M., Taylor, F., Lord-Bessen, J., Yip, C., Greenwood, M., Tang, J. & Cavo, M., 03.2023, In: HEMASPHERE. 7, 3, p. e843

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma

    San Miguel, J. F., Weisel, K. C., Song, K. W., Delforge, M., Karlin, L., Goldschmidt, H., Moreau, P., Banos, A., Oriol, A., Garderet, L., Cavo, M., Ivanova, V., Alegre, A., Martinez-Lopez, J., Chen, C., Renner, C., Bahlis, N. J., Yu, X., Teasdale, T., Sternas, L., Jacques, C., Zaki, M. H. & Dimopoulos, M. A., 10.2015, In: HAEMATOLOGICA. 100, 10, p. 1334-9 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study

    Moreau, P., Joshua, D., Chng, W-J., Palumbo, A., Goldschmidt, H., Hájek, R., Facon, T., Ludwig, H., Pour, L., Niesvizky, R., Oriol, A., Rosiñol, L., Suvorov, A., Gaidano, G., Pika, T., Weisel, K., Goranova-Marinova, V., Gillenwater, H. H., Mohamed, N., Aggarwal, S., Feng, S. & Dimopoulos, M. A., 01.2017, In: LEUKEMIA. 31, 1, p. 115-122 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma

    Mai, E. K., Huhn, S., Miah, K., Poos, A. M., Scheid, C., Weisel, K. C., Bertsch, U., Munder, M., Berlanga, O., Hose, D., Seckinger, A., Jauch, A., Blau, I. W., Hänel, M., Salwender, H. J., Benner, A., Raab, M. S., Goldschmidt, H. & Weinhold, N., 04.01.2023, In: BLOOD CANCER J. 13, 1, p. 1

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg: Report of the University Cancer Center Hamburg

    Weisel, K. C., Morgner-Miehlke, A., Petersen, C., Fiedler, W., Block, A., Schafhausen, P., Knobloch, J. K. & Bokemeyer, C., 07.05.2020, In: ONCOL RES TREAT. 43, 6, p. 307-313 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  31. Improved Follow-Up and Response Monitoring of Thoracic Cage Involvement in Multiple Myeloma Using a Novel CT Postprocessing Software: The Lessons We Learned

    Bier, G., Mustafa, D. F., Kloth, C., Weisel, K., Ditt, H., Nikolaou, K. & Horger, M., 01.2016, In: AM J ROENTGENOL. 206, 1, p. 57-63 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Improved MDCT monitoring of pelvic myeloma bone disease through the use of a novel longitudinal bone subtraction post-processing algorithm

    Horger, M., Thaiss, W. M., Ditt, H., Weisel, K., Fritz, J., Nikolaou, K., Liao, S. & Kloth, C., 07.2017, In: EUR RADIOL. 27, 7, p. 2969-2977 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Improvement of diagnostic confidence for detection of multiple myeloma involvement of the ribs by a new CT software generating rib unfolded images: Comparison with 5- and 1-mm axial images

    Homann, G., Weisel, K., Mustafa, D. F., Ditt, H., Nikolaou, K. & Horger, M., 07.2015, In: SKELETAL RADIOL. 44, 7, p. 971-9 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Improving outcomes for patients with relapsed multiple myeloma: Challenges and considerations of current and emerging treatment options

    Ramasamy, K., Gay, F., Weisel, K., Zweegman, S., Mateos, M. V. & Richardson, P., 09.2021, In: Blood reviews. 49, p. 100808

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  35. Increased incidence of immune thrombocytopenia (ITP) in 2021 correlating with the ongoing vaccination campaign against COVID-19 in a tertiary center - A monocentric analysis

    Schaefers, C., Paulsen, F-O., Frenzel, C., Weisel, K., Bokemeyer, C. & Seidel, C., 04.2023, In: BRIT J HAEMATOL. 201, 2, p. 222-226 5 p.

    Research output: SCORING: Contribution to journal › Short publication › Research › peer-review

  36. Increasing bone sclerosis during bortezomib therapy in multiple myeloma patients: results of a reduced-dose whole-body MDCT study

    Schulze, M., Weisel, K., Grandjean, C., Oehrlein, K., Zago, M., Spira, D. & Horger, M., 01.2014, In: AM J ROENTGENOL. 202, 1, p. 170-9 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma

    Costello, C., Davies, F. E., Cook, G., Vela-Ojeda, J., Omel, J., Rifkin, R. M., Berdeja, J., Puig, N., Usmani, S. Z., Weisel, K., Zonder, J. A., Terpos, E., Spencer, A., Leleu, X., Boccadoro, M., Thompson, M. A., Romanus, D., Stull, D. M. & Hungria, V., 05.2019, In: FUTURE ONCOL. 15, 13, p. 1411-1428 18 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials

    Gavriatopoulou, M., Chari, A., Chen, C., Bahlis, N., Vogl, D. T., Jakubowiak, A., Dingli, D., Cornell, R. F., Hofmeister, C. C., Siegel, D., Berdeja, J. G., Reece, D., White, D., Lentzsch, S., Gasparetto, C., Huff, C. A., Jagannath, S., Baz, R., Nooka, A. K., Richter, J., Abonour, R., Parker, T. L., Yee, A. J., Moreau, P., Lonial, S., Tuchman, S., Weisel, K. C., Mohty, M., Choquet, S., Unger, T. J., Li, K., Chai, Y., Li, L., Shah, J., Shacham, S., Kauffman, M. G. & Dimopoulos, M. A., 09.2020, In: LEUKEMIA. 34, 9, p. 2430-2440 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis

    Karagiannis, P., Sänger, L., Alsdorf, W., Weisel, K., Fiedler, W., Kluge, S., Wichmann, D., Bokemeyer, C. & Fuhrmann, V., 24.06.2020, In: CANCERS. 12, 6, 1678.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma

    Rodriguez-Otero, P., Usmani, S., Cohen, A. D., van de Donk, N. W. C. J., Leleu, X., Pérez-Larraya, J. G., Manier, S., Nooka, A. K., Mateos, M. V., Einsele, H., Minnema, M., Cavo, M., Derman, B. A., Puig, N., Gay, F., Ho, P. J., Chng, W-J., Kastritis, E., Gahrton, G., Weisel, K., Nagarajan, C., Schjesvold, F., Mikhael, J., Costa, L., Raje, N. S., Zamagni, E., Hájek, R., Weinhold, N., Yong, K., Ye, J. C., Sidhana, S., Merlini, G., Martin, T., Lin, Y., Chari, A., Popat, R., Kaufman, J. L. & International Myeloma Working Group, 05.2024, In: LANCET ONCOL. 25, 5, p. e205-e216

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  41. International Symposium and Workshop on hematopoietic stem cells VII, University of Tübingen, Germany, September 18-20, 2008

    Weisel, K. C., Dick, J., Fibbe, W. E. & Kanz, L., 09.2009, In: ANN NY ACAD SCI. 1176, p. 1-17 17 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Intravascular lymphoma - a rare cause of hemolytic anemia and neurologic disorders

    Weisel, K. C., Brugger, W., Kröber, S. M., Kaiserling, E. & Kanz, L., 2004, In: HEMATOL J. 5, 5, p. 444-6 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma

    Leypoldt, L. B., Tichy, D., Besemer, B., Hänel, M., Raab, M. S., Mann, C., Munder, M., Reinhardt, H. C., Nogai, A., Görner, M., Ko, Y-D., de Wit, M., Salwender, H., Scheid, C., Graeven, U., Peceny, R., Staib, P., Dieing, A., Einsele, H., Jauch, A., Hundemer, M., Zago, M., Požek, E., Benner, A., Bokemeyer, C., Goldschmidt, H. & Weisel, K. C., 01.01.2024, In: J CLIN ONCOL. 42, 1, p. 26-37 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial

    Leypoldt, L. B., Besemer, B., Asemissen, A. M., Hänel, M., Blau, I. W., Görner, M., Ko, Y-D., Reinhardt, H. C., Staib, P., Mann, C., Lutz, R., Munder, M., Graeven, U., Peceny, R., Salwender, H., Jauch, A., Zago, M., Benner, A., Tichy, D., Bokemeyer, C., Goldschmidt, H. & Weisel, K. C., 03.2022, In: LEUKEMIA. 36, 3, p. 885-888 4 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  45. Ixazomib-lenalidomide-dexamethasone in routine clinical practice:effectiveness in relapsed/refractory multiple myeloma

    Hájek, R., Minařík, J., Straub, J., Pour, L., Jungova, A., Berdeja, J. G., Boccadoro, M., Brozova, L., Spencer, A., Rhee, F. V., Vela-Ojeda, J., Thompson, M. A., Abonour, R., Chari, A., Cook, G., Costello, C. L., Davies, F. E., Hungria, V. T., Lee, H. C., Leleu, X., Puig, N., Rifkin, R. M., Terpos, E., Usmani, S. Z., Weisel, K. C., Zonder, J. A., Bařinová, M., Kuhn, M., Šilar, J., Čápková, L., Galvez, K., Lu, J., Elliott, J., Stull, D. M., Ren, K. & Maisnar, V., 07.2021, In: FUTURE ONCOL. 17, 19, p. 2499-2512 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma

    Ludwig, H., Poenisch, W., Knop, S., Egle, A., Schreder, M., Lechner, D., Hajek, R., Gunsilius, E., Krenosz, K. J., Petzer, A., Weisel, K., Niederwieser, D., Einsele, H., Willenbacher, W., Melchardt, T., Greil, R. & Zojer, N., 10.2019, In: BRIT J CANCER. 121, 9, p. 751-757 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

    Benboubker, L., Dimopoulos, M. A., Dispenzieri, A., Catalano, J., Belch, A. R., Cavo, M., Pinto, A., Weisel, K., Ludwig, H., Bahlis, N., Banos, A., Tiab, M., Delforge, M., Cavenagh, J., Geraldes, C., Lee, J-J., Chen, C., Oriol, A., de la Rubia, J., Qiu, L., White, D. J., Binder, D., Anderson, K., Fermand, J-P., Moreau, P., Attal, M., Knight, R., Chen, G., Van Oostendorp, J., Jacques, C., Ervin-Haynes, A., Avet-Loiseau, H., Hulin, C., Facon, T. & FIRST Trial Team, 04.09.2014, In: NEW ENGL J MED. 371, 10, p. 906-17 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Lenalidomide in relapsed and refractory multiple myeloma disease: feasibility and benefits of long-term treatment

    Zago, M., Oehrlein, K., Rendl, C., Hahn-Ast, C., Kanz, L. & Weisel, K., 12.2014, In: ANN HEMATOL. 93, 12, p. 1993-9 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma

    Baertsch, M-A., Mai, E. K., Hielscher, T., Bertsch, U., Salwender, H. J., Munder, M., Fuhrmann, S., Dührsen, U., Brossart, P., Neben, K., Schlenzka, J., Kunz, C., Raab, M. S., Hillengaß, J., Jauch, A., Seckinger, A., Hose, D., Luntz, S., Sonneveld, P., Lokhorst, H., Martin, H., Goerner, M., Hoffmann, M., Lindemann, H-W., Bernhard, H., Blau, I. W., Scheid, C., Besemer, B., Weisel, K. C., Hänel, M., Dürig, J., Goldschmidt, H. & German-speaking Myeloma Multicenter Group (GMMG), 07.01.2021, In: BLOOD CANCER J. 11, 1, p. 1

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

    Mateos, M-V., Weisel, K., De Stefano, V., Goldschmidt, H., Delforge, M., Mohty, M., Cavo, M., Vij, R., Lindsey-Hill, J., Dytfeld, D., Angelucci, E., Perrot, A., Benjamin, R., van de Donk, N. W. C. J., Ocio, E. M., Scheid, C., Gay, F., Roeloffzen, W., Rodriguez-Otero, P., Broijl, A., Potamianou, A., Sakabedoyan, C., Semerjian, M., Keim, S., Strulev, V., Schecter, J. M., Vogel, M., Wapenaar, R., Nesheiwat, T., San-Miguel, J., Sonneveld, P., Einsele, H. & Moreau, P., 05.2022, In: LEUKEMIA. 36, 5, p. 1371-1376 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 4 5 Next